Belgium’s food safety agency AFSCA-FAVV has ordered Ferrero to suspend production at its plant in Arlon, Belgium due to a link that has been confirmed between more than a hundred cases of salmonella and Kinder chocolate production.
According to AFSCA-FAVV, the decision to temporarily close the plant was taken after finding the information from Ferrero to be incomplete.
Ferrero, the Italian chocolate giant, canceled a number of its Kinder products last week owing to salmonella concerns.
The tainted chocolate was made at Ferrero's Arlon plant, where salmonella was discovered in a filter in December.
According to the Food Standards Agency in the United Kingdom, at least 63 instances of salmonella have been connected to Kinder products, with the majority of the cases occurring in children under the age of five.
Other countries affected by recalls included the US and several European states.
Ferrero acknowledged internal inefficiencies that caused delays in retrieving and sharing information promptly.
Ferrero revealed that the plant would only reopen once certified by the authorities.


California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Philippines Manufacturing PMI Hits Nine-Month High Despite Weak Confidence Outlook
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
RBA Raises Interest Rates by 25 Basis Points as Inflation Pressures Persist
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits 



